Observational study of etrasimod for ulcerative colitis
Treatments studied
Part of Digestive system clinical trials.
This study watches how well etrasimod works for adults with moderate to severe ulcerative colitis (UC). You must already be prescribed etrasimod by your doctor, and the study collects information through a web-based tool.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old.
- You have been diagnosed with moderate to severe ulcerative colitis.
- Your doctor has prescribed etrasimod for your UC.
- You are willing and able to use a web-based tool on a personal device to answer questions.
- You have not used etrasimod before or taken part in an etrasimod study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the medicine etrasimod can help children with moderate to severe ulcerative colitis. You may still be able to join even if you are already taking other treatments for your condition.
This trial provides access to an investigational medicine called etrasimod for people with ulcerative colitis who have not been helped by at least three other treatments, or who cannot take them. It's a compassionate use program, meaning it's for patients with no other options.
This study tests a new combination treatment for moderate-to-severe ulcerative colitis (UC). The goal is to see if adding an investigational drug to an existing UC therapy helps reduce symptoms and improve the lining of the colon.
This trial tests new medicines for people with moderate to severe ulcerative colitis who haven't found relief with standard treatments. Participants will receive one of several investigational drugs (these are not yet approved and are being studied for safety and tolerability). The goal is to see if the drugs are safe and if they might help control symptoms.
This study tests an investigational medication called LY4268989 for adults with moderate to severe ulcerative colitis (UC). It's for people who have tried other treatments without success. The goal is to see if the drug can reduce inflammation and improve symptoms.
This study tests the drug etrasimod in people with active ulcerative colitis (UC). It looks at how well the drug works and its safety. If you have UC that is not well controlled, this trial might help you manage your condition.
Hear when a new Colitis, Ulcerative trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.